We're talking with Dr. Kratz about how My MS Toolkit was developed and what makes it such a powerful online tool for people living with MS.
We're also talking about the latest petitions filed with the Supreme Court in the battle over the Affordable Care Act (and why this is so vitally important to people affected by MS!). If you're using gabapentin (Neurontin) to manage MS pain, we'll tell you about the warning that was just issued by the FDA.
Yet another study gives us yet another reason to start disease-modifying therapy as soon as possible. And we'll explain why collecting real-world data about MS is so important, and what a team of MS experts is recommending to improve the process of real-world data collection and analysis.
National MS Society Joins 23 Other Patient Organizations in Requesting Supreme Court Expedites Its Review of the ACA 3:00
FDA Issues Warning About Gabapentinoids 6:51
Disease-Modifying Therapy Use Has Changed the ‘Natural History' of Relapsing-Remitting MS 7:57
Paper Explores How Real-World Data Can Be Better Leveraged to Speed Solutions to People Living with MS 9:34
My Interview with Dr. Anna Kratz 15:04
Share This Episode 36:00
Download the RealTalk MS App 36:29
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: http://realtalkms.com/123
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
RealTalk MS Episode 123
Hosted By: Jon Strum
Guests: Dr. Anna Kratz
Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Gabapentinoids, ACA, RealTalkMS